Loading…
← CockpitCompetitor Analysis › 2609.HK Bayzed Health Group, Inc.Open in the cockpit ↗

Bayzed Health Group, Inc.2609.HKCompetitor analysis, valuation and peers

Hong Kong · HKD·Health Care›Hospital/Nursing Management
Momentum laggard 16
Mkt cap
$375M
US dollars, full cap
Free float
13%
of shares outstanding
$/day
$907,785
20-day average traded
Fwd P/E
n/m
no positive forecast
ROIC−WACC
-3.0 pp
WACC 5.5%
Hurdle
+6 pp
Req g minus delivered
Close · HKDHK$2.25
1D-2.6%
1W-10.0%
1M-15.7%
3M-24.9%
6M-58.1%
YTD-41.1%
1Y-66.2%
ATR %5.0%
52w lowhigh68.0% off high

What Bayzed Health does

Employees: 1,998

Bayzed Health at a glance

Size Bayzed Health (2609.HK) is a Hong Kong Health Care company (Hospital/Nursing Management) with a market value of $375M, the 834th largest of 885 Hong Kong companies the cockpit tracks. Shares closed at HK$2.25 on 18 Nov 2026.

Performance Over six months the shares fell 58.1%, against -3.4% for the median peer and -14.0% for the Hong Kong market (cap-weighted) — lowest of 19 in its peer set.

Growth Revenue fell 1.9% over the last twelve months (peer median +11.9%); the operating margin is 4.7% (peer median 10.7%).

Valuation It trades at 2.4× enterprise value to sales against a peer median of 2.6× (10th cheapest of 21).

Price implies For today's price to make sense, revenue must grow about 15% a year for seven years (Req g). Recent delivered growth is +9%, so the hurdle is +6 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.

Capital Return on invested capital runs 3.0 points below its cost of capital (5.5% WACC).

Relative performance

40608010021 May 202621 Aug 202618 Nov 2026Peer median 952609.HK 44
Six months, rebased to 100: Bayzed Health against the median of its 20 peers (local-currency closes).

Bayzed Health financials

Reported figures in HKD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueHK$1.26BHK$1.21BHK$1.29BHK$1.18BHK$933M
Revenue growth—-6%+9%+27%—
Gross profitHK$216MHK$207MHK$195MHK$171MHK$70.0M
EBITDAHK$170MHK$123MHK$127MHK$114MHK$36.6M
Net incomeHK$32.5M-HK$14.1M-HK$14.6M-HK$29.2M-HK$67.5M
Free cash flowHK$214MHK$179MHK$140MHK$71.4MHK$81.0M
Capital expenditureHK$62.4MHK$41.1MHK$50.4MHK$59.5MHK$42.3M
Total debtn/aHK$606MHK$550MHK$584MHK$514M

Quarterly statements and history in the cockpit →

Bayzed Health competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%0%+50%-20%0%+20%+40%3012391515VOXINDRAMEDCO6062301103VMDQC7GHCARTEMISMEDKOVAIHCGGDSJLHLRHKPARKHOSPS2609.HK6-month return →1-month return →
Up and to the right = strong over both horizons. Bayzed Health is the large dot.

Fundamentals: revenue growth against valuation

0%+10%+20%2×4×6×3012391515VOXINDRAMEDCO6062KMCSHIL301103VMDQC7GHCARTEMISMEDKOVAIA50HCGPARASHLTHGDSCBAVJLHLRHKPARKHOSPS2609.HKRevenue growth (TTM) →EV / Sales →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Bayzed Health is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%0%20%40%3012391515VOXINDRAMEDCOKMCSHIL301103VMDQC7GHCARTEMISMEDKOVAIA50GDSCBAVPARKHOSPS2609.HKGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Bayzed Health is the large dot.

Bayzed Health competitors and peer comparison

How Bayzed Health compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Bayzed Health against its 20 peers (data as of 18 Nov 2026)
Measure2609.HKPeer medianRank in peer set
1-month return-15.7%+2.1%2nd lowest of 20
6-month return-58.1%-3.4%lowest of 19
Distance from 52-week high-68.0%-18.4%lowest of 21
Revenue growth (TTM)-1.9%+11.9%lowest of 21
Operating margin4.7%10.7%4th lowest of 21
EV / Sales2.4×2.6×10th cheapest of 21
Growth the price implies (Req g, 7 yrs)14.7%6.5%7th most demanding of 17
Growth delivered (Del g)+9.2%+16.0%4th lowest of 17
Hurdle (Req g minus delivered)+5.6 pp-7.1 pp4th most demanding of 17
ROIC minus cost of capital-3.0 pp+1.1 pp7th lowest of 21
EV / EBITDA17.8×12.9×8th most expensive of 18
Net debt / EBITDA-0.2×0.6×5th least indebted of 18

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginEV / SalesReq gDelivered g
Bayzed Health 2609.HKHong Kong$375M-58%-2%5%2.4×14.7%+9.2%
Bright Eye Hospital 301239.SZChina$377M-26%+11%9%1.3×-5.1%+15.5%
China Resources Medical 1515.HKHong Kong$393M-10%0%6%0.4×-7.5%+26.3%
Voxel VOX.WAPoland$393M+59%+14%24%2.7×1.2%+12.2%
Indraprastha Medical INDRAMEDCO.NSIndia$351M0%+11%15%1.9×14.9%+19.3%
Charm Care 6062.TJapan$402M+57%+6%11%1.2×-0.4%+16.4%
KMC Speciality Hospitals (India) KMCSHIL.NSIndia$346Mn/a+35%23%9.8×19.0%+24.4%
Liaoning He Eye Hospital 301103.SZChina$342M-20%+3%4%0.9×-4.2%+5.4%
Viemed Healthcare VMDUnited States$333M-9%+22%8%1.1×6.8%+15.5%
Q & M Dental Group (Singapore) QC7.SISingapore$326M-26%+16%9%2.5×7.7%+7.5%
Garofalo Health Care GHC.MIItaly$508M-3%+4%10%1.4×1.7%+18.3%
Artemis Medicare Services ARTEMISMED.NSIndia$582M+25%+15%13%4.8×48.5%+21.5%
Kovai Medical Center & Hospital KOVAI.NSIndia$759M+22%+17%21%4.1×17.4%+18.1%
Thomson Medical A50.SISingapore$923M-18%+6%10%5.5×21.2%+11.8%
HealthCare Global Enterprises HCG.NSIndia$955M-7%+13%8%3.9×n/an/a
Paras Healthcare PARASHLTH.NSIndia$962Mn/a+24%11%6.4×n/an/a
Ramsay Generale de Sante GDS.PAFrance$969M-25%+3%4%0.9×6.1%+6.0%
Clinica Baviera CBAV.MCSpain$1.01B+2%+11%20%2.8×2.3%+19.7%
Jupiter Life Line Hospitals JLHL.NSIndia$1.01B+9%+17%16%6.0×n/an/a
Rhon-klinikum RHK.DEGermany$1.06B+15%+4%-51%0.6×n/an/a
Park Medi World PARKHOSPS.NSIndia$1.10B-4%+21%21%5.8×22.1%+10.2%

Questions

Which companies are Bayzed Health's closest peers?
The cockpit's peer set: Bright Eye Hospital (301239.SZ), China Resources Medical (1515.HK), Voxel (VOX.WA), Indraprastha Medical (INDRAMEDCO.NS), Charm Care (6062.T), KMC Speciality Hospitals (India) (KMCSHIL.NS), Liaoning He Eye Hospital (301103.SZ), Viemed Healthcare (VMD).
Is Bayzed Health expensive compared with its peers?
On ev / sales it trades at 2.4× against a peer median of 2.6×, 10th cheapest of 21 in its peer set. For today's price to make sense, revenue must grow about 15% a year for seven years (Req g). Recent delivered growth is +9%, so the hurdle is +6 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
How has Bayzed Health stock performed?
Over six months to 18 Nov 2026 the shares returned -58.1% against -3.4% for the median peer; over one year -66.2%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.